What is the market doing?
What the tape says about BCRX
BioCryst Pharmaceuticals, Inc. is +18% over the past year while the S&P 500 is +23%: 5.0 points behind the market.
+18%
1-year return · S&P 500 +23%
- vs 200-day average
- +18%
vs 200-day average · a clear uptrend
- RSI (14)
- 57
RSI (14) · neutral
- Below its 52-week high
- −7.3%
Below its 52-week high
Details›
- Last close2026-08-26
- $9.82
- 1 monthS&P 500 +3.7%
- +4.6%
- 1 yearS&P 500 +23%
- +18%
- 5 yearsS&P 500 +87%
- −39%
- vs 50-day average$9.31
- +5.5%
- 52-week high
- $10.59
- 52-week low
- $6.24
- Annualised volatility
- 50%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$605K
| Year | Return |
|---|---|
| 2026 (year to date) | +26% |
| 2025 | +3.7% |
| 2024 | +26% |
| 2023 | −48% |
| 2022 | −17% |
| 2021 | +86% |
| 2020 | +116% |
| 2019 | −57% |
| 2018 | +64% |
| 2017 | −22% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | −2.3% |
| Feb | 10 | 7 of 10 | +7.6% |
| Mar | 10 | 2 of 10 | −3.2% |
| Apr | 10 | 4 of 10 | +2.4% |
| May | 10 | 7 of 10 | +9.4% |
| Jun | 10 | 6 of 10 | +0.03% |
| Jul | 11 | 6 of 11 | +0.87% |
| Aug | 11 | 7 of 11 | +6.8% |
| Sep | 10 | 3 of 10 | −4.5% |
| Oct | 10 | 4 of 10 | −5.6% |
| Nov | 10 | 7 of 10 | +13% |
| Dec | 10 | 7 of 10 | +7.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #2 of 28 by Smart Score